Tema Etfs LLC Buys 9,180 Shares of Itron, Inc. $ITRI

by · The Cerbat Gem

Tema Etfs LLC lifted its stake in shares of Itron, Inc. (NASDAQ:ITRIFree Report) by 21.8% in the 3rd quarter, Holdings Channel reports. The fund owned 51,206 shares of the scientific and technical instruments company’s stock after acquiring an additional 9,180 shares during the quarter. Tema Etfs LLC’s holdings in Itron were worth $6,378,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Twin Peaks Wealth Advisors LLC acquired a new position in Itron in the 2nd quarter worth $30,000. Bessemer Group Inc. lifted its holdings in shares of Itron by 125.7% in the second quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after purchasing an additional 142 shares in the last quarter. Salomon & Ludwin LLC bought a new stake in shares of Itron in the third quarter valued at about $42,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after buying an additional 268 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after buying an additional 81 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, SVP Christopher E. Ware sold 343 shares of the firm’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $33,102.93. Following the completion of the sale, the senior vice president directly owned 18,774 shares in the company, valued at approximately $1,811,878.74. This trade represents a 1.79% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Joan S. Hooper sold 948 shares of Itron stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $91,491.48. Following the transaction, the chief financial officer owned 87,446 shares of the company’s stock, valued at $8,439,413.46. The trade was a 1.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 2,971 shares of company stock worth $286,731 in the last 90 days. 1.45% of the stock is owned by corporate insiders.

Itron Price Performance

NASDAQ:ITRI opened at $99.31 on Monday. Itron, Inc. has a 1-year low of $90.11 and a 1-year high of $142.00. The company has a current ratio of 2.17, a quick ratio of 1.91 and a debt-to-equity ratio of 0.46. The firm has a fifty day simple moving average of $97.95 and a 200 day simple moving average of $117.17. The stock has a market capitalization of $4.55 billion, a PE ratio of 17.86, a P/E/G ratio of 0.55 and a beta of 1.49.

Itron (NASDAQ:ITRIGet Free Report) last posted its quarterly earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.06. The firm had revenue of $581.63 million for the quarter, compared to analyst estimates of $578.49 million. Itron had a net margin of 10.69% and a return on equity of 17.82%. The company’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.84 earnings per share. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. On average, research analysts expect that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have commented on ITRI. JPMorgan Chase & Co. boosted their target price on Itron from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Thursday, October 16th. Oppenheimer set a $145.00 price objective on shares of Itron and gave the stock an “outperform” rating in a research report on Friday, October 31st. Zacks Research cut shares of Itron from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 12th. Baird R W lowered shares of Itron from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 31st. Finally, Wall Street Zen raised shares of Itron from a “hold” rating to a “buy” rating in a research report on Tuesday, January 6th. Nine analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $138.10.

View Our Latest Analysis on ITRI

Itron Profile

(Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Featured Stories

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRIFree Report).